Combination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer Patients
Clinical trial NCT03342417 · TERMINATED
Trial details
- NCT number
- NCT03342417
- Sponsor
- ExcellaBio LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-14
- Primary completion
- 2019-05-29
- Enrollment
- 5
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.